4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-24-001870
Chief Business Officer sold 18,000 shares at $10.93 ($196,740)
- Chief Business Officer acquired 18,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Virani Shafique · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +18,000 | $2.22 | $39,960 | 154,748 | D |
| 2024-01-16 | Sale : show line 2 in the form 10b5-1 | −18,000 | $10.93 | $196,740 | 136,748 | D |
| Open-market sales · 18,000 sh · avg $10.93 · $196,740 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −18,000 | $2.22 | 2030-03-03 | 18,000 | 361,469 | D |
Loading xslF345X05/doc4.xml…